methyl-CpG binding protein 2 gene therapy (The University Of Edinburgh/The University Of Glasgow)

N/A

Report date: 2025/05/20 15:00:34

Base Information

Drug Namemethyl-CpG binding protein 2 gene therapy (The University Of Edinburgh/The University Of Glasgow)
Drug Alias NameN/A
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adeno-associated virus vector
Mechanisms of ActionMethyl-CpG-binding protein 2 modulators
TargetsMethyl-CpG-binding protein 2
Therapy Area/IndicationsRett Syndrome
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesThe University Of EdinburghThe University Of Glasgow
China Registration ClassN/A

Develop Information

Active CompaniesThe University Of GlasgowThe University Of Edinburgh
Inactive CompaniesN/A
Active IndicationsRett Syndrome
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A